BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+38.98%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$165M
AUM Growth
+$165M
(+47%)
Cap. Flow
+$19.3M
Cap. Flow
% of AUM
11.69%
Top 10 Holdings %
Top 10 Hldgs %
78.72%
Holding
53
New
7
Increased
8
Reduced
3
Closed
2
Top Buys
| 1 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
$12.7M |
| 2 |
BLUE
bluebird bio
BLUE
|
$3.66M |
| 3 |
Soleno Therapeutics
SLNO
|
$1.39M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$1.11M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$966K |
Top Sells
| 1 |
VRML
Vermillion, Inc.
VRML
|
$2.68M |
| 2 |
Gilead Sciences
GILD
|
$769K |
| 3 |
EQM
EQM Midstream Partners, LP
EQM
|
$605K |
| 4 |
InflaRx
IFRX
|
$183K |
| 5 |
Workhorse Group
WKHS
|
$174K |
Sector Composition
| 1 | Healthcare | 95.54% |
| 2 | Energy | 1.09% |
| 3 | Consumer Discretionary | 0.16% |
| 4 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioCryst Pharmaceuticals
BCRX
$1.74B
| $95K | 0.06% |
20,000
| – | – |
|
|
EQM
52
DELISTED
EQM Midstream Partners, LP
EQM
| – | – |
-51,250
| Closed | -$605K |
|
|
VRML
53
DELISTED
Vermillion, Inc.
VRML
| – | – |
-3,221,933
| Closed | -$2.68M |
|